ORITAVANCIN (Tenkasi®)

Clinical Indication

Acute bacterial skin and skin structure infections (ABSSSI) in adults

Comments

Reviewed by TAS September 22

Date of classification

October 2022

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.